Ledger.Open graph →
SEC Form D · Amendment · filed August 8, 2014

Gliacure, Inc

Offering
$6.0M
Sold
$5.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Joseph S. Zakrzewski · Boston, MADirectorPhilip Haydon · Boston, MAExec · DirectorMichael Szulczewski · Boston, MADirectorWalter Dewey · Boston, MADirectorHenry Wilde · Pittsburgh, PADirectorSam A. Paulos · Plano, TXDirectorLarry A. Calton · Plano, TXExec · DirectorC. Collins L. Anderson · San Antonio, TXDirectorYolande S. Haydon · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗